Evidence map›Paper›PMID 36184049›Full record

ArticleInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2022

Dynamics of SARS-CoV-2 lineages in French Guiana in 2020-2021: 4 epidemic waves with cross-influences from Europe and South America.

Alexandra Miliu, Anne Lavergne, Tiphanie Succo, Claire Laizé, Audrey Andrieu, Antoine Enfissi, Vincent Enouf, Sylvie Van der Werf, Denis Blanchet, Magalie Demar and 7 more

Abstract read
In one paragraph

Article in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Alexandra MiliuSanté publique France, Regional unit French Guiana, Cayenne, French Guiana. Electronic address: guyane@santepubliquefrance.fr.
Anne LavergneNational Reference Center for Respiratory Viruses, Institut Pasteur de la Guyane, Cayenne, French Guiana.
Tiphanie SuccoSanté publique France, Regional unit French Guiana, Cayenne, French Guiana.
Claire LaizéAgence régionale de santé (ARS) Guyane, Cayenne, French Guiana.
Audrey AndrieuSanté publique France, Regional unit French Guiana, Cayenne, French Guiana.
Antoine EnfissiNational Reference Center for Respiratory Viruses, Institut Pasteur de la Guyane, Cayenne, French Guiana.
Vincent EnoufNational Reference Center for Respiratory Viruses, Institut Pasteur, Paris, France.
Sylvie Van der WerfNational Reference Center for Respiratory Viruses, Institut Pasteur, Paris, France. Electronic address: sylvie.van-der-werf@pasteur.fr.
Denis BlanchetClinical Laboratory, Centre Hospitalier de Cayenne (CHC), Cayenne, French Guiana.
Magalie DemarClinical Laboratory, Centre Hospitalier de Cayenne (CHC), Cayenne, French Guiana. Electronic address: magalie.demar@ch-cayenne.fr.
Jean-François CarodClinical laboratory of Centre Hospitalier de l'Ouest Guyanais (CHOG), Saint Laurent du Maroni, French Guiana. Electronic address: jf.carod@ch-ouestguyane.fr.
Thierry CarageCarage laboratory associated to Kourou hospital center (CHK), Kourou, French Guiana.
Claude FlamandNational Reference Center for Respiratory Viruses, Institut Pasteur de la Guyane, Cayenne, French Guiana.
Sourakhata TireraNational Reference Center for Respiratory Viruses, Institut Pasteur de la Guyane, Cayenne, French Guiana.
Etienne Simon-LorièreInstitut Pasteur, Université de Paris, G5 Evolutionary Genomics of RNA viruses, 75015 Paris, France. Electronic address: etienne.simon-loriere@pasteur.fr.
Cyril RousseauSanté publique France, Regional unit French Guiana, Cayenne, French Guiana.
Dominique RoussetNational Reference Center for Respiratory Viruses, Institut Pasteur de la Guyane, Cayenne, French Guiana. Electronic address: drousset@pasteur-cayenne.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the first cases of SARS-CoV-2 infection in Wuhan in December 2019, this RNA virus gave rise to different viral lineages with different virological, epidemiological and immunological properties. Here we describe the dynamics of circulation of SARS-CoV-2 lineages in an Amazonian South American French overseas territory, French Guiana (FG). The data analyzed are based on the general epidemic course, and genomic surveillance data come from whole genome sequencing (WGS) as well as typing PCRs. From March 2020 to October 2021, four COVID-19 epidemic waves were observed in FG with an evolution of viral lineages influenced by virus introductions from continental France and above all by land-based introductions from neighbouring countries. The third epidemic wave from March to June 2021 was driven by a predominant Gamma introduced from Brazil and a less frequent Alpha introduced from France. This coexistence was completely substituted by Delta that initiated the fourth epidemic wave.

Indexed as

COVID-19SARS-CoV-2BrazilEuropeFrench GuianaHumansDynamics of circulationFrench GuianaGenomic surveillanceSARS-CoV2 variantsVariant of concern

Identifiers

PMID36184049
PMCPMC9529336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.